Sean A. McCarthy - 16 Jun 2021 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
President and CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Issuer symbol
CTMX
Transactions as of
16 Jun 2021
Net transactions value
-$704,470
Form type
4
Filing time
21 Jun 2021, 15:51:22 UTC
Previous filing
16 Jun 2021
Next filing
13 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale $704,470 -100,000 -52% $7.04 93,118 16 Jun 2021 See footnote F1, F2, F3
holding CTMX Common Stock 7,849 16 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
F3 This transaction was executed in multiple trades in prices ranging from $6.88 to $7.135, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.